Alfresa Holdings (2784) · InitiativeFirst statedLatest Earnings (2026-08-05): "Advanced"
Strengthening clinical development, regulatory submissions and post-marketing surveillance capabilities through the acquisition of CRO and PMS businesses
First written in FY2025-H1. 4 of 5 entries say "Advanced", first in 2026-03-31. Latest entry: 2026-08-05.
5entries
3years
4from disclosures
How it moved
Same theme, other companies
Strengthening CRO and PMS Capabilities Through the Acquisition of ArkMS株式会社A theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first